KINDLING BIO LTD
Company number 16308967 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£192,994
Balance sheet as at 2026-03-31
What it does
The principal activity of the company is the development of paediatric-focused gene therapies for the treatment of cancer
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2025-03-11
- Employees
- 2 (2026 accounts)
- Registered office
- Innovation Gateway, The London Cancer Hub, Cotswold Road, Sutton, London, SM2 5NG
- Postcode
- SM2 5NG
- Capital
- 108 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2026-03-31
- Next due by
- 2027-12-31
- Financial year end
- 31 March
Confirmation statement
- Last statement dated
- 2026-03-10
- Next due by
- 2027-03-24
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 3 current · 1 resigned
DEEP SCIENCE VENTURES
Corporate Director
Aleck William Evan Gregory, Dr JONES
Director
Jeffrey, Dr DREW
Director
At this address
Among the biggest employers
of 1,120 similar companies in SM — measured against the wider sector, with 2 staff.